Report overview
This report contains market size and forecasts of Intranasal Drug Delivery System in global, including the following market information:
Global Intranasal Drug Delivery System Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Intranasal Drug Delivery System Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Intranasal Drug Delivery System companies in 2021 (%)
The global Intranasal Drug Delivery System market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Nasal Drops Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Intranasal Drug Delivery System include Aptar Pharma, Nemera, Teleflex, Mystic Pharmaceuticals, Zeteo Medical, Johnson & Johnson, GlaxoSmithKline Plc, Aegis Therapeutics LLC and H&T Presspart Manufacturing Ltd., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Intranasal Drug Delivery System manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Intranasal Drug Delivery System Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Intranasal Drug Delivery System Market Segment Percentages, by Type, 2021 (%)
Nasal Drops
Nasal Sprays
Nasal Gels
Nasal Suspensions and Emulsion
Nasal Powders
Global Intranasal Drug Delivery System Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Intranasal Drug Delivery System Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Home Care
Others
Global Intranasal Drug Delivery System Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Intranasal Drug Delivery System Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Intranasal Drug Delivery System revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Intranasal Drug Delivery System revenues share in global market, 2021 (%)
Key companies Intranasal Drug Delivery System sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Intranasal Drug Delivery System sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Aptar Pharma
Nemera
Teleflex
Mystic Pharmaceuticals
Zeteo Medical
Johnson & Johnson
GlaxoSmithKline Plc
Aegis Therapeutics LLC
H&T Presspart Manufacturing Ltd.
AstraZeneca Plc
Becton
BD
Novartis AG
Vectura Group Plc
